Narayanan Geetha, Soman Lali V, Haridas Lakshmi, Sugathan Harish
Department of Medical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
J Neurosci Rural Pract. 2017 Jul-Sep;8(3):466-468. doi: 10.4103/jnrp.jnrp_376_16.
Myeloid sarcoma (MS) or chloroma is a rare extramedullary tumor composed of extramedullary proliferation of blasts of granulocytic, monocytic, erythroid, or megakaryocytic lineage occurring at sites outside the bone marrow. MS occurs in 2%-8% of patients with acute myeloid leukemia (AML), sometimes it occurs as the presenting manifestation of relapse in a patient in remission. We describe the case of a young male with AML in remission for 6 years presenting with central nervous system symptoms. Magnetic resonance imaging showed an extra-axial altered intensity lesion in the parasagittal parietal region, infiltrating anterosuperiorly into anterior falx, and posterosuperior aspect of the superior sagittal sinus. A biopsy from the lesion was diagnostic of MS which was positive for myeloperoxidase. He did not have any other sites of disease. He has received chemotherapy with FLAG (Fludarabine, Cytosine arabinoside) followed by cranial irradiation and is in complete remission.
髓系肉瘤(MS)或绿色瘤是一种罕见的髓外肿瘤,由粒细胞、单核细胞、红系或巨核细胞系的原始细胞在骨髓外部位增殖形成。MS发生于2%-8%的急性髓系白血病(AML)患者中,有时它会作为缓解期患者复发的首发表现出现。我们描述了一例AML缓解6年的年轻男性患者出现中枢神经系统症状的病例。磁共振成像显示矢状旁顶叶区域有一个轴外强度改变的病变,向上前浸润至前纵裂,以及上矢状窦的后上部分。病变活检诊断为MS,髓过氧化物酶呈阳性。他没有其他疾病部位。他接受了FLAG(氟达拉滨、阿糖胞苷)化疗,随后进行了颅脑照射,目前处于完全缓解状态。